Life Sciences

Axial Biotherapeutics Announces Positive Topline Results from Phase 1b/2a Clinical Trial of AB-2004 for the Treatment of Autism Spectrum Disorder
3 April 2020

Axial Biotherapeutics Announces Positive Topline Results from Phase 1b/2a Clinical Trial of AB-2004 for the Treatment of Autism Spectrum Disorder

Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders,...

Read the press release
MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics
6 February 2020

MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics

MaaT Pharma announced today an €18 million Series B financing round including a microbiome-focused US investor, SymBiosis, LLC, and support from its existing investors...

Read more
Seventure Partners invests in Novobind, the Vancouver-headquartered animal health biologics business
9 March 2020

Seventure Partners invests in Novobind, the Vancouver-headquartered animal health biologics business

NovoBind Livestock Therapeutics Inc. is pleased to announce the successful close of an oversubscribed Series A investment round with a wide range of strategic and financial...

Read the press release
Seventure Partners invests in the start-up TIBOT Technologies, the pioneer in poultry robotics
9 October 2019

Seventure Partners invests in the start-up TIBOT Technologies, the pioneer in poultry robotics

TIBOT Technologies announces a 3-million-euro round of financing and the incorporation of new shareholders Demeter and Seventure Partners a pioneer in the Indian Poultry...

Read the press release
C-section babies are missing key microbes via nature.com
20 September 2019

C-section babies are missing key microbes via nature.com

How a baby is born has a profound impact on their microbiome — the community of microbes that colonize the body. That’s the finding of the largest ever study of the newborn...

Read more
Seventure Partners Life Sciences Corporate Update Health for Life: March 2019 – June 2019
1 July 2019

Seventure Partners Life Sciences Corporate Update Health for Life: March 2019 – June 2019

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, is pleased to provide an update on its Health...

Read the press release
String Bio Raises Capital to Develop and Manufacture Next-Generation Alternative Proteins in India
28 June 2019

String Bio Raises Capital to Develop and Manufacture Next-Generation Alternative Proteins in India

String Bio, a biotechnology company, announced today that it raised capital to develop next-generation alternate proteins for the global feed and food companies. The products...

Read the press release
LiMM Therapeutics incorporated to translate breakthrough science into first in class therapeutic agents
25 June 2019

LiMM Therapeutics incorporated to translate breakthrough science into first in class therapeutic agents

LiMM Therapeutics was created to lead development of a new class of therapeutic agents - neuronal reprogrammers of innate lymphocytes. The company is based on pioneering...

Read the press release
European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests €3.5M ($3.9M) to prepare the next growth phase
28 May 2019

European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests €3.5M ($3.9M) to prepare the next growth phase

Domain Therapeutics announces today that it has secured a €3.5M ($3.9M) investment from existing shareholder Seventure Partners, to accelerate its next growth phase. Since...

Read the press release

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse